Jean Bousquet, Honorary Professor of Pulmonary Medicine at Montpellier University, France has chaired GINA (Global Initiative for Asthma: 1999-2000), ARIA and the WHO Global Alliance against Chronic Respiratory Diseases (GARD, 2006-2013). He has a research interest in the mechanisms of allergy, multimorbidity of allergic diseases, severe asthma and the digital transformation of health and care to sustain Planetary Health. He has published over 1,000 papers and is the most influential author in asthma. Jean Bousquet has always combined his research, clinical and public health interests. He performed translational research from a clinical observation in his clinic to (i) the assessment of the disease burden (epidemiology), (ii) the understanding of the mechanisms, (iii) the implementation of the results to populations developing guidelines, national or international programmes, and (iv) the deployment of the results with the EU or WHO. His research, which initially focussed on allergens and immunotherapy (1980s), was then directed towards asthma (1990). He confirmed inflammation in asthma (1990) and proposed and demonstrated the concept of airways remodelling in asthma (1992). He was a pioneer in allergy multimorbidity (1999) and proposed a new definition for IgE-mediated diseases (2015). He is now interested in the digital transformation of health with DG CONNECT and DG Santé, in air pollution (POLLAR: Impact of air POLLution in Asthma and Rhinitis, EIT Health), in Planetary Health and, more recently, in COVID-19. • Has edited and authored 10 books including one allergy textbook. • Has been author or co-author of over 950 peer-reviewed papers posted in Medline. • Has an H factor (Clarivate) of 130. Three papers (first author) are cited over 2,000 times and 6 others over 1,000 times (2 as first author). • Was listed as the most influential author in asthma (2018) and has published 5 of the 22 best cited papers in asthma (among the 190,000 papers published between 1960 and 2017, Qu et al, Respir Med, 2018, 137: 206-212). • Was listed as one of the 800 most cited authors in all scientific fields among over 6.6 million researchers (Iaonidis et al, PLoS Biol. 2020 Oct 16;18(10):e3000918). He has been the editor of European Respiratory Review and of Allergy (second ranking journal in the field, 2003-2009, IF: 6.2). He is currently the editor of Clinical Translational Allergy (IF 2016: 0; IF 2020: 5.1).